Soleno Therapeutics (SLNO) News Today → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free SLNO Stock Alerts $46.16 +0.50 (+1.10%) (As of 05/17/2024 08:54 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15, 2024 | globenewswire.comSoleno Therapeutics Stands with the Prader-Willi Syndrome CommunityMay 15, 2024 | americanbankingnews.comSoleno Therapeutics (NASDAQ:SLNO) Given New $59.00 Price Target at OppenheimerMay 14, 2024 | marketbeat.comBaird R W Upgrades Soleno Therapeutics (NASDAQ:SLNO) to "Strong-Buy"Baird R W upgraded Soleno Therapeutics to a "strong-buy" rating in a research note on Friday.May 14, 2024 | americanbankingnews.comSoleno Therapeutics (NASDAQ:SLNO) Earns Outperform Rating from Analysts at Robert W. BairdMay 13, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) PT Lowered to $59.00Oppenheimer cut their price target on Soleno Therapeutics from $65.00 to $59.00 and set an "outperform" rating for the company in a research note on Monday.May 13, 2024 | markets.businessinsider.comSoleno Therapeutics (SLNO) Receives a Buy from Stifel NicolausMay 13, 2024 | americanbankingnews.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Receives $55.60 Consensus PT from AnalystsMay 12, 2024 | americanbankingnews.comSoleno Therapeutics (NASDAQ:SLNO) Stock Price Down 6.1%May 11, 2024 | msn.comBaird Initiates Coverage of Soleno Therapeutics (SLNO) with Outperform RecommendationMay 10, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Trading Down 6.1%Soleno Therapeutics (NASDAQ:SLNO) Shares Down 6.1%May 10, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Rating of "Buy" by AnalystsShares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) have been given a consensus recommendation of "Buy" by the five analysts that are presently covering the stock, MarketBeat.com reports. Five investment analysts have rated the stock with a buy recommendation. The average twelve-moMay 10, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Coverage Initiated at Robert W. BairdRobert W. Baird initiated coverage on Soleno Therapeutics in a research note on Friday. They issued an "outperform" rating and a $72.00 price target on the stock.May 10, 2024 | investorplace.comSLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q1 2024May 9, 2024 | markets.businessinsider.comSoleno Therapeutics’ DCCR Poised for FDA Approval and Blockbuster Sales: An Analyst’s Bullish OutlookMay 9, 2024 | globenewswire.comSoleno Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial ResultsMay 9, 2024 | marketbeat.comVivo Capital LLC Increases Stock Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Vivo Capital LLC boosted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 162.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 8,418,093 shares of the company's stock after acquiring an additional 5,215,000 sMay 8, 2024 | finance.yahoo.comWhile institutions invested in Soleno Therapeutics, Inc. (NASDAQ:SLNO) benefited from last week's 4.8% gain, private equity firms stood to gain the mostMay 3, 2024 | nasdaq.comSoleno Therapeutics Prices Public Offering Of 3 Mln Shares At $46/shr; Stock Down In After-hoursMay 2, 2024 | globenewswire.comSoleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common StockMay 2, 2024 | globenewswire.comSoleno Therapeutics Announces Proposed Public Offering of Common StockMay 2, 2024 | insidertrades.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Major Shareholder Vivo Opportunity, Llc Sells 750,000 SharesApril 30, 2024 | globenewswire.comSoleno Therapeutics Announces Peer-Reviewed Publication of Data Comparing DCCR Treatment to the Natural History of Prader-Willi SyndromeApril 29, 2024 | marketwatch.comSoleno Therapeutics Gets Breakthrough Therapy Designation for Diazoxide CholineApril 29, 2024 | marketwatch.comSoleno Therapeutics Shares Rise 37% After Breakthrough Designation for Diazoxide CholineApril 29, 2024 | seekingalpha.comSoleno: Mid-2024 NDA Filing For PWS Treatment Is A Major Catalyst To WatchApril 29, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Shares Gap Up to $37.89Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up to $37.89April 29, 2024 | fool.comWhy Soleno Therapeutics Stock Is Skyrocketing TodayApril 29, 2024 | globenewswire.comSoleno Therapeutics Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome (PWS)April 19, 2024 | globenewswire.comSoleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)April 15, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Shares Up 3.4%Soleno Therapeutics (NASDAQ:SLNO) Trading 3.4% HigherApril 14, 2024 | marketbeat.comCarlyle Group Inc. Acquires 564,242 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)Carlyle Group Inc. increased its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 24.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,857,804 shares of the company's stock after acquiriApril 5, 2024 | investing.comSoleno Therapeutics CEO sells over $780k in company stockApril 4, 2024 | insidertrades.comInsider Selling: Soleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Sells 2,218 Shares of StockApril 4, 2024 | finance.yahoo.comInsider Sell: CFO James Mackaness Sells 5,175 Shares of Soleno Therapeutics Inc (SLNO)April 4, 2024 | finance.yahoo.comCEO Bhatnagar Anish Sells 18,980 Shares of Soleno Therapeutics Inc (SLNO)April 4, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Insider Kristen Yen Sells 2,218 SharesSoleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) insider Kristen Yen sold 2,218 shares of the company's stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $41.34, for a total value of $91,692.12. Following the sale, the insider now directly owns 23,422 shares of the company's stock, valued at approximately $968,265.48. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.March 31, 2024 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Sees Large Increase in Short InterestSoleno Therapeutics, Inc. (NASDAQ:SLNO - Get Free Report) saw a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 2,300,000 shares, a growth of 36.9% from the February 29th total of 1,680,000 shares. Based on an average trading volume of 294,800 shares, the days-to-cover ratio is presently 7.8 days. Currently, 12.2% of the company's shares are short sold.March 26, 2024 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Trading Up 5.6%Soleno Therapeutics (NASDAQ:SLNO) Trading Up 5.6%March 19, 2024 | marketbeat.comWalleye Capital LLC Takes $1.37 Million Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO)Walleye Capital LLC purchased a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 46,244 shares of the company's stock, valued at approximately $1,365,000. Walleye Capital LLC owned 0.March 16, 2024 | finance.yahoo.comSLNO Apr 2024 40.000 putMarch 16, 2024 | finance.yahoo.comSLNO Apr 2024 35.000 putMarch 12, 2024 | marketbeat.comSchonfeld Strategic Advisors LLC Acquires Shares of 23,200 Soleno Therapeutics, Inc. (NASDAQ:SLNO)Schonfeld Strategic Advisors LLC bought a new position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 23,200 shares of the company's stock, valued at approximateMarch 11, 2024 | bizjournals.comConstruction of Soleno's $22M pipe factory in Saratoga underwayMarch 11, 2024 | finance.yahoo.comWe're Not Worried About Soleno Therapeutics' (NASDAQ:SLNO) Cash BurnMarch 8, 2024 | globenewswire.comSoleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)March 8, 2024 | markets.businessinsider.comPiper Sandler Reaffirms Their Buy Rating on Soleno Therapeutics (SLNO)March 7, 2024 | investorplace.comSLNO Stock Earnings: Soleno Therapeutics Misses EPS for Q4 2023March 6, 2024 | globenewswire.comSoleno Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial ResultsMarch 6, 2024 | marketbeat.comRA Capital Management L.P. Acquires New Holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO)RA Capital Management L.P. acquired a new stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 1,239,000 shares of the company's stock, valued at approximatelMarch 1, 2024 | marketbeat.com683 Capital Management LLC Buys New Shares in Soleno Therapeutics, Inc. (NASDAQ:SLNO)683 Capital Management LLC bought a new position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 87,000 shares of the company's stock, valued at approximately $2,567,000. 683 Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Did you know you can now trade Bitcoin in your regular brokerage account? (Ad)You see, thanks to one unique investor's brand new discovery - anyone with a regular brokerage account can now tap into the most explosive asset in history! That means you can skip the hassle of opening a Coinbase account… Bypass the fees and hard-to-remember passwords… Heck, you don’t even need a crypto wallet! >> Tap here to sign up and join them for the imminent workshop SLNO Media Mentions By Week SLNO Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SLNO News Sentiment▼0.100.42▲Average Medical News Sentiment SLNO News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SLNO Articles This Week▼92▲SLNO Articles Average Week Get Soleno Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SLNO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: InMode News CONMED News BioLife Solutions News Rhythm Pharmaceuticals News Larimar Therapeutics News Edap Tms News FONAR News Rockwell Medical News LivaNova News Integer News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SLNO) was last updated on 5/20/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaHe called Apple at $1.49 and now he says: “Buy these 6 AI stocks.”InvestorPlaceMost important medical advance in 100 yearsThe Oxford ClubCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMissed NVDA? Buy this AI stock NOWChaikin AnalyticsForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Soleno Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
